BCAB logo

BioAtla (BCAB) EBIT

BCAB Annual EBIT

-$129.69 M
-$21.55 M-19.93%

31 December 2023

BCAB EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCAB Quarterly EBIT

-$11.27 M
+$10.70 M+48.71%

30 September 2024

BCAB Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCAB TTM EBIT

-$86.23 M
+$23.75 M+21.59%

30 September 2024

BCAB TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCAB EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-19.9%+48.7%+21.6%
3 y3 years-276.3%+61.2%+13.5%
5 y5 years-362.7%+39.7%-65.5%

BCAB EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.9%at lowat high+69.7%at high+33.5%
5 y5-year-359.5%at low-1233.7%+69.7%<-9999.0%+33.5%
alltimeall time-362.7%at low-1233.7%+69.7%<-9999.0%+33.5%

BioAtla EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$11.27 M(-48.7%)
-$86.23 M(-21.6%)
June 2024
-
-$21.97 M(-10.2%)
-$109.98 M(-12.2%)
Mar 2024
-
-$24.46 M(-14.3%)
-$125.21 M(-3.4%)
Dec 2023
-$129.69 M(+19.9%)
-$28.54 M(-18.5%)
-$129.69 M(-0.0%)
Sept 2023
-
-$35.02 M(-5.9%)
-$129.71 M(+7.3%)
June 2023
-
-$37.20 M(+28.6%)
-$120.87 M(+7.2%)
Mar 2023
-
-$28.93 M(+1.3%)
-$112.72 M(+4.2%)
Dec 2022
-$108.14 M
-$28.56 M(+9.1%)
-$108.14 M(+5.0%)
Sept 2022
-
-$26.18 M(-9.9%)
-$102.97 M(+3.3%)
June 2022
-
-$29.05 M(+19.3%)
-$99.72 M(-1.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$24.35 M(+4.1%)
-$101.05 M(+5.9%)
Dec 2021
-$95.40 M(+176.8%)
-$23.39 M(+2.0%)
-$95.40 M(+7.9%)
Sept 2021
-
-$22.93 M(-24.5%)
-$88.40 M(+14.8%)
June 2021
-
-$30.38 M(+62.5%)
-$77.02 M(+47.8%)
Mar 2021
-
-$18.70 M(+14.1%)
-$52.11 M(+51.2%)
Dec 2020
-$34.46 M(+22.1%)
-$16.39 M(+42.0%)
-$34.46 M(+82.2%)
Sept 2020
-
-$11.55 M(+111.2%)
-$18.92 M(+156.7%)
June 2020
-
-$5.47 M(+417.3%)
-$7.37 M(+287.5%)
Mar 2020
-
-$1.06 M(+25.1%)
-$1.90 M(+125.1%)
Dec 2019
-$28.23 M(+0.7%)
-$845.00 K
-$845.00 K
Dec 2018
-$28.03 M
-
-

FAQ

  • What is BioAtla annual earnings before interest & taxes?
  • What is the all time high annual EBIT for BioAtla?
  • What is BioAtla annual EBIT year-on-year change?
  • What is BioAtla quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for BioAtla?
  • What is BioAtla quarterly EBIT year-on-year change?
  • What is BioAtla TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for BioAtla?
  • What is BioAtla TTM EBIT year-on-year change?

What is BioAtla annual earnings before interest & taxes?

The current annual EBIT of BCAB is -$129.69 M

What is the all time high annual EBIT for BioAtla?

BioAtla all-time high annual earnings before interest & taxes is -$27.24 M

What is BioAtla annual EBIT year-on-year change?

Over the past year, BCAB annual earnings before interest & taxes has changed by -$21.55 M (-19.93%)

What is BioAtla quarterly earnings before interest & taxes?

The current quarterly EBIT of BCAB is -$11.27 M

What is the all time high quarterly EBIT for BioAtla?

BioAtla all-time high quarterly earnings before interest & taxes is -$845.00 K

What is BioAtla quarterly EBIT year-on-year change?

Over the past year, BCAB quarterly earnings before interest & taxes has changed by +$10.70 M (+48.71%)

What is BioAtla TTM earnings before interest & taxes?

The current TTM EBIT of BCAB is -$86.23 M

What is the all time high TTM EBIT for BioAtla?

BioAtla all-time high TTM earnings before interest & taxes is -$845.00 K

What is BioAtla TTM EBIT year-on-year change?

Over the past year, BCAB TTM earnings before interest & taxes has changed by +$23.75 M (+21.59%)